The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalence
Open accessAbstract
This report describes a cross-sectional survey of the prevalence of antibodies to hepatitis C virus (anti-HCV) in a rural Egyptian community in the Nile Delta. One half of the village households were systematically selected and examined by questionnaire and testing sera for anti-HCV and HCV RNA. Blood samples were obtained from 3,888 (75.4%) of 5,156 residents ≥5 years of age; an additional 111 samples were obtained from children younger than 5 years. Overall, 973 (24.3%) of 3,999 residents were anti-HCV-positive, and the age- and gender-adjusted seroprevalence was 23.7%. Anti-HCV prevalence increased sharply with age, from 9.3% in those 20 years of age and younger to >50% in those older than 35 years. Currently or previously married individuals were more likely to be seropositive than those never married, controlling for age (Mantel-Haenszel risk ratio = 1.8; 95% CI: 1.3, 2.6). Of the 905 anti-HCV-positive samples tested, 65% were also positive for HCV RNA. Active schistosomal infection was not associated with anti-HCV status; however, history of antischistosomal injection therapy (reported by 19% of anti-HCV positives) was a risk for anti-HCV (age-adjusted risk ratio = 1.3; 95% CI: 1.2, 1.5). This study, the largest community-based survey to date, supports earlier reports of high levels of anti-HCV among adults in rural areas of Egypt, although many of those who are seropositive will not have active liver disease. The large reservoir of HCV infection in the community provides an opportunity to investigate risk factors for transmission, the natural history of infection and effectiveness of preventive methodologies, and raises concern about the prospect of an increasing incidence of chronic liver disease in the coming decades.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06527-7 · Cited by 1,131
Self-citationAlter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
Esteban, J. I., Viladomiu, L., Gonzalez, A., Roget, M., Genescà, J., Esteban, R., López-Talavera, J. C., Hernández, J. M., Vargas, V., Buti, M., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90485-6 · Cited by 886
Alter, M. J. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450170079026 · Cited by 615
Di Bisceglie, A. M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07361-3 · Cited by 288
Epidemiology of Hepatitis C Virus: A Preliminary Study in Volunteer Blood Donors
Stevens, C. E. (1990) · JAMA · doi:10.1001/jama.1990.03440010047028 · Cited by 242
Darwish, M. A., Raouf, T. A., Rushdy, P., Constantine, N. T., Rao, M. R., & Edelman, R. (1993) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.49.440 · Cited by 172
Hepatitis C Virus Infection in Spouses of Patients with Type C Chronic Liver Disease
Akahane, Y., Kojima, M., Sugai, Y., Sakamoto, M., Miyazaki, Y., Tanaka, T., Tsuda, F., Mishiro, S., Okamoto, H., Miyakawa, Y., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00005 · Cited by 167
High Seroprevalence of Hepatitis C Infection among Risk Groups in Egypt
Abdel-Wahab, M. F., Zakaria, S., Kamel, M., Abdel-Khaliq, M. K., Mabrouk, M., Salama, H., Esmat, G., Thomas, D. L., & Strickland, G. T. (1994) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1994.51.563 · Cited by 141
Self-citationHepatitis C antibody prevalence in blood donors in different governorates in Egypt
Arthur, R. R., Hassan, N. F., Abdallah, M. Y., El-Sharkawy, M. S., Saad, M. D., Hackbart, B. G., & Imam, I. Z. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90070-5 · Cited by 126
High HCV prevalence in Egyptian blood donors
Kamel, M. A., Ghaffar, Y., Wasef, M., Wright, M., Clark, L., & Miller, F. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91508-6 · Cited by 115
El-Sayed, N., Gomatos, P. J., Rodier, G. R., Wierzba, T. F., Darwish, A., Khashaba, S., & Arthur, R. R. (1996) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.55.179 · Cited by 66
Cited by
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Epidemiology of hepatitis C virus infection
Alter, M. J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i17.2436 · Cited by 1,339
Epidemiology of Hepatocellular Carcinoma
Bosch, F. X., Ribes, J., Cléries, R., & Díaz, M. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.12.009 · Cited by 1,131
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
Sievert, W., Altraif, I., Razavi, H. A., Abdo, A., Ahmed, E. A., AlOmair, A., Amarapurkar, D., Chen, C., Dou, X., El Khayat, H., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02540.x · Cited by 534
The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis
Mohamoud, Y. A., Mumtaz, G. R., Riome, S., Miller, D., & Abu-Raddad, L. J. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-288 · Cited by 413
Metadata
- Authors
- Abdel-Aziz, F., Habib, M., Mohamed, M. K., Abdel-Hamid, M., Gamil, F., Madkour, S., Mikhail, N. N., Thomas, D., Fix, A. D., Strickland, T. G., Anwar, W., & Sallam, I.
- Venue
- Hepatology
- Published
- 2000-07
- Volume
- 32
- Issue
- 1
- Pages
- 111-115
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2160537948
- Cited by
- 265
- References
- 12
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.